BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37032423)

  • 1. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.
    Hoogwater FJH; Kuipers H; de Meijer VE; Maulat C; Muscari F; Polak WG; van Hoek B; Jézéquel C; Alwayn IPJ; Ijzermans JNM; Mohkam K; Mabrut JY; Van Vilsteren FGI; Adam JP; Chiche L; Chebaro A; Boleslawski E; Dubbeld J; Murad SD; Rayar M; Porte RJ
    BJS Open; 2023 Mar; 7(2):. PubMed ID: 37032423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
    Darwish Murad S; Kim WR; Harnois DM; Douglas DD; Burton J; Kulik LM; Botha JF; Mezrich JD; Chapman WC; Schwartz JJ; Hong JC; Emond JC; Jeon H; Rosen CB; Gores GJ; Heimbach JK
    Gastroenterology; 2012 Jul; 143(1):88-98.e3; quiz e14. PubMed ID: 22504095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
    Loveday BPT; Knox JJ; Dawson LA; Metser U; Brade A; Horgan AM; Gallinger S; Greig PD; Moulton CA
    J Surg Oncol; 2018 Feb; 117(2):213-219. PubMed ID: 29480952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center experience of liver transplantation for perihilar cholangiocarcinoma.
    Ahmed O; Vachharajani N; Chang SH; Park Y; Khan AS; Chapman WC; Doyle MBM
    HPB (Oxford); 2022 Apr; 24(4):461-469. PubMed ID: 34465528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma.
    Darwish Murad S; Kim WR; Therneau T; Gores GJ; Rosen CB; Martenson JA; Alberts SR; Heimbach JK
    Hepatology; 2012 Sep; 56(3):972-81. PubMed ID: 22290335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
    Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
    HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for cholangiocarcinoma: current best practice.
    DeOliveira ML
    Curr Opin Organ Transplant; 2014 Jun; 19(3):245-52. PubMed ID: 24811436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Strategy of Liver Transplantation for Locally Advanced Unresectable Perihilar Cholangiocarcinoma Using Living Grafts With Simultaneous Resection of Recipients' Hepatic Artery and Portal Vein Without Neoadjuvant Radiation: A Case Report.
    Miyagi S; Fujio A; Nakagawa K; Tokodai K; Kashiwadate T; Miyazawa K; Sasaki K; Matsumura M; Nishimaki H; Hibi T; Kamei T; Unno M
    Transplant Proc; 2022; 54(6):1643-1647. PubMed ID: 35810018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol.
    Bhat M; Hathcock M; Kremers WK; Darwish Murad S; Schmit G; Martenson J; Alberts S; Rosen CB; Gores GJ; Heimbach J
    Transpl Int; 2015 Dec; 28(12):1383-91. PubMed ID: 26183487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?
    Yilmaz S; Carr BI; Akbulut S
    J Gastrointest Cancer; 2022 Dec; 53(4):1104-1112. PubMed ID: 34738188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes.
    Acher AW; Weber SM; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):555-566. PubMed ID: 33577361
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of Patients With Incidental Perihilar Cholangiocarcinoma: An Old and a Persistent Burden for Liver Transplantation.
    Krasnodębski M; Grąt M; Wierzchowski M; Szczęśniak M; Morawski M; Zając K; Patkowski W; Zieniewicz K
    Transplant Proc; 2020 Oct; 52(8):2507-2511. PubMed ID: 32307142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
    Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
    J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
    van Keulen AM; Buettner S; Erdmann JI; Pratschke J; Ratti F; Jarnagin WR; Schnitzbauer AA; Lang H; Ruzzenente A; Nadalin S; Cescon M; Topal B; Olthof PB; Groot Koerkamp B;
    Br J Surg; 2023 Apr; 110(5):599-605. PubMed ID: 36918735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol.
    Zaborowski A; Heneghan HM; Fiore B; Stafford A; Gallagher T; Geoghegan J; Maguire D; Hoti E
    Transplantation; 2020 Oct; 104(10):2097-2104. PubMed ID: 31972704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation for Peri-hilar Cholangiocarcinoma.
    Tan EK; Taner T; Heimbach JK; Gores GJ; Rosen CB
    J Gastrointest Surg; 2020 Nov; 24(11):2679-2685. PubMed ID: 32671802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
    Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
    Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.